High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19

INTRODUCTION: High-flow nasal cannula oxygen therapy (HFNC) has been shown to be a useful therapy in the treatment of patients with Acute Respiratory Distress Syndrome (ARDS), but its efficacy is still unknown in patients with COVID-19. Our objective is to describe its utility as therapy for the tre...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Multidiscip Respir Med
Główni autorzy: Panadero, Carolina, Abad-Fernández, Araceli, Rio-Ramirez, Mª Teresa, Acosta Gutierrez, Carmen Maria, Calderon-Alcala, Mariara, Lopez-Riolobos, Cristina, Matesanz-Lopez, Cristina, Garcia-Prieto, Fernando, Diaz-Garcia, Jose Maria, Raboso-Moreno, Beatriz, Vasquez-Gambasica, Zully, Andres-Ruzafa, Pilar, Garcia-Satue, Jose Luis, Calero-Pardo, Sara, Sagastizabal, Belen, Bautista, Diego, Campos, Alfonso, González, Marina, Grande, Luis, Jimenez Fernandez, Marta, Santiago-Ruiz, Jose L., Caravaca Perez, Pedro, Alcaraz, Andres Jose
Format: Artigo
Język:Inglês
Wydane: PAGEPress Publications, Pavia, Italy 2020
Hasła przedmiotowe:
Original Research Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7512942/
https://ncbi.nlm.nih.gov/pubmed/32983456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/mrm.2020.693
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy